Ifomid M 1G Injection

By Ifomid M

Rx

1 Injection in a Vial

Composition icon

Composition

Mesna(200mg) + Ifosfamide(1gm)

Manufacturer - United Biotech Pvt Ltd icon

Manufacturer - United Biotech Pvt Ltd

FC/B-1 (Extn.), Mohan Co-operative Industrial Estate Mathura Road, New Delhi - 110 044

Expires on or after icon

Expires on or after

July, 2025

About Ifomid M 1G Injection

Ifomid M 1G Injection is a prescription medicine used in cancer treatment. It is a combination of two medicines that work together to prevent the growth and multiplication of cancer cells. By doing so, it helps in destroying the tumor. This injection should only be administered under the supervision of a healthcare professional. It is important not to self-administer this medicine to prevent any risks.

Common side effects of Ifomid M 1G Injection may include nausea, vomiting, hair loss, anemia, and a decrease in white blood cell count. Your doctor may recommend blood tests before or during the treatment to monitor these effects. In some cases, you may be given supplements to address any deficiencies that may arise from the medication. To support your health during the treatment, it is advisable to include more vegetables and fruits in your diet.

Before starting Ifomid M 1G Injection, it is crucial to inform your doctor about any allergies to this medication, other medicines you are taking, pregnancy, breastfeeding, or any existing health conditions. It is also important to abstain from consuming alcohol while on this medication. For your safety, it is strictly advised not to drive or operate heavy machinery while undergoing treatment with Ifomid M 1G Injection.


Benefits

Ifomid M 1G Injection offers a range of benefits, especially in the treatment of various types of cancers such as testicular cancer, bladder cancer, lung cancer, ovarian cancer, cervical cancer, and musculoskeletal cancer. This medication is a combination of two powerful medicines, Ifosfamide and Mesna, that work together to slow down or stop the growth of cancer cells in the body. Mesna, a key component of Holoxan Uromitexan, plays a crucial role in reducing the risk of bladder inflammation and bleeding, which are common and serious side effects associated with Ifosfamide treatment.

Patients undergoing treatment with Ifomid M 1G Injection are advised to maintain proper hydration by drinking at least 1-2 liters of water every 24 hours throughout the treatment process. By following this recommendation, patients can help to mitigate the risk of bladder complications and support the effectiveness of the medication in combating cancer cells. Overall, the benefits of Ifomid M 1G Injection lie in its ability to target and combat various cancers while also minimizing the adverse effects associated with the treatment, ultimately improving the overall outcome for patients battling cancer.


How to use the Ifomid M 1G Injection

To use Ifomid M 1G Injection, your doctor or nurse will administer the medicine to you. It is essential not to self-administer this medication. Follow your healthcare provider's instructions carefully and receive the injection as directed. Ensure that the injection is given in the appropriate dosage and at the recommended intervals. If you have any questions or concerns about how to use Holoxan Uromitexan, do not hesitate to consult your doctor or healthcare team for guidance. Always prioritize safety and follow the instructions provided by your healthcare provider for the best results.


Uses of Ifomid M 1G Injection

Ifomid M 1G Injection is primarily used in the treatment of cancer. This medication is specifically indicated for cancer patients to help in managing their condition. It is commonly administered to cancer patients as part of their chemotherapy regimen. By targeting cancer cells, Holoxan Uromitexan helps in slowing down the growth and spread of cancer in the body. The effectiveness of this injection in fighting cancer makes it a crucial component in the treatment plan for many cancer patients.


What conditions Ifomid M 1G Injection treats?

Ifomid M 1G Injection is specifically used in cancer treatment, targeting various types of cancers such as testicular, bladder, lung, ovarian, cervical, and musculoskeletal cancers. It works by hindering the growth of cancer cells. This medication comprises Ifosfamide and Mesna, where Mesna helps in preventing bladder inflammation and bleeding. Patients may experience side effects like nausea, vomiting, hair loss, anemia, and lowered white blood cell count. Regular blood tests and dietary adjustments are recommended during treatment. It is crucial to inform the healthcare provider about any existing medical conditions to ensure safe administration.


Should you consult a doctor?

It is important to seek a doctor if you experience any of the following conditions while taking Ifomid M 1G Injection: persistent nausea, vomiting, hair loss, anemia (low red blood cell count), blood in urine, decreased white blood cell count, increased risk of infection, or signs of neurotoxicity. These symptoms may require medical attention for proper management. Additionally, inform your doctor if you have any known allergies to the medication, are pregnant or breastfeeding, or have any existing health conditions. Regular blood tests may be recommended by your doctor to monitor your response to the treatment. Remember to avoid alcohol consumption and refrain from driving or operating heavy machinery while undergoing this treatment. If you have concerns about side effects, consult your doctor promptly.


Side effects of Ifomid M 1G Injection

When using Ifomid M 1G Injection, some common side effects may occur. These side effects are usually not severe and may go away as your body gets used to the medication. However, it is important to speak with your doctor if you experience persistent side effects or if you are concerned about them. Possible side effects include hair loss, nausea, vomiting, anemia (low red blood cell count), blood in urine, decreased white blood cell count, increased risk of infection, and neurotoxicity. It's essential to monitor how you feel and discuss any symptoms with your healthcare provider to ensure your well-being.


Safety advice

scroll

liver

Ifomid M 1G Injection should be used carefully in individuals with liver problems. It may be necessary to adjust the dosage of Ifomid M 1G Injection in such cases. It is important to seek advice from your doctor regarding the use of this medication if you have liver issues.

scroll

kidney

Ifomid M 1G Injection requires caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor for guidance.

scroll

alcohol

It is not safe to consume alcohol with Ifomid M 1G Injection.

scroll

driving

Ifomid M 1G Injection may have side effects that could impact your driving. Be cautious and assess your ability to drive safely while using this medication.

scroll

pregnancy

Ifomid M 1G Injection is not safe to use during pregnancy due to the risk it poses to the developing baby. However, in rare life-threatening situations, a doctor may consider prescribing it if the benefits outweigh the potential risks. Please consult your doctor regarding its use during pregnancy.

scroll

breastfeeding

Ifomid M 1G Injection is not recommended for use while breastfeeding as it may be harmful to the baby, causing potential toxicity.


Consumption warning before consuming Ifomid M 1G Injection

Before consuming Ifomid M 1G Injection, it is crucial to understand that this medication is used in cancer treatment and should only be taken as prescribed by a healthcare professional. Do not attempt to self-administer this injection. Inform your doctor about any known allergies to this medication. Common side effects may include nausea, vomiting, hair loss, anemia, and reduced white blood cell count. Your doctor may recommend blood tests before and during treatment and may provide supplements to address any deficiencies caused by the medicine. It is advisable to increase intake of fruits and vegetables to counteract these deficiencies.

Notify your doctor about any other medications you are taking, pregnancy, breastfeeding, or any existing medical conditions. Avoid alcohol consumption while on this treatment. It is strictly advised not to drive or operate heavy machinery during the course of this treatment.


What if you forgot to take Ifomid M 1G Injection?

If you happen to miss a dose of Ifomid M 1G Injection, it is important to reach out to your doctor for guidance. Consulting your doctor in such situations can help ensure that you receive proper instructions on the next steps to take. It is crucial to follow your healthcare provider's advice regarding missed doses to maintain the effectiveness and safety of your treatment. Your doctor may provide specific instructions on how to proceed, such as rescheduling the missed dose or adjusting your treatment plan accordingly. By seeking guidance from your doctor, you can help minimize any potential impact of a missed dose on your overall treatment regimen.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic Class-
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

441

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 01-Oct-2024